J.Molner AS (OTSE:MOLNR) Pre-Tax Income : €-2.44 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. J.Molner AS's pretax income for the six months ended in Dec. 2024 was €-1.46 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was €-2.44 Mil. J.Molner AS's pretax margin was -147.32%.

During the past 4 years, J.Molner AS's highest Pretax Margin was -64.95%. The lowest was -322.92%. And the median was -140.92%.

J.Molner AS Pre-Tax Income Historical Data

The historical data trend for J.Molner AS's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Pre-Tax Income Chart

J.Molner AS Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Pre-Tax Income

-0.33

-0.62

-1.09

-2.44

J.Molner AS Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial			-0.37	-0.45	-0.64	-0.98	-1.46

Competitive Comparison of J.Molner AS's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, J.Molner AS's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

J.Molner AS's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, J.Molner AS's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where J.Molner AS's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

J.Molner AS Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

J.Molner AS's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.937	+	0	+	-0.34	+	0	+	-0.162
	=	-2.44

J.Molner AS's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.188	+	0	+	-0.203	+	0	+	-0.066
	=	-1.46

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.44 Mil.

J.Molner AS (OTSE:MOLNR) Pre-Tax Income Explanation

J.Molner AS's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.457	/	0.989
	=	-147.32%

During the past 4 years, J.Molner AS's highest Pretax Margin was -64.95%. The lowest was -322.92%. And the median was -140.92%.

J.Molner AS Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of J.Molner AS's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

J.Molner AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618

Website

https://www.jmolner.com

J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS Headlines

No Headlines